申请人:Wallace Eli
公开号:US20050153942A1
公开(公告)日:2005-07-14
Disclosed are compounds of the Formula I
and pharmaceutically acceptable salts and prodrugs thereof, wherein R
1
, R
2
, R
7
, R
8
and R
9
, W, X, Y and Z are as defined in the specification. Such compounds are MEK inhibitors and are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
本发明涉及公式I的化合物及其药学上可接受的盐和前药,其中R1、R2、R7、R8和R9、W、X、Y和Z如规范中所定义。这些化合物是MEK抑制剂,可用于治疗哺乳动物的增殖过度疾病,如癌症和炎症,以及炎症病症。本发明还涉及使用这些化合物治疗哺乳动物的增殖过度疾病的方法和含有这些化合物的制药组合物。